- Home
- FBP vs CRNX Comparison
FBP vs CRNX Comparison
Compare FBP & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBP | CRNX |
|---|---|---|
| Founded | 1948 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | FBP | CRNX |
|---|---|---|
| Price | $22.43 | $42.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $24.13 | ★ $75.78 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 01-27-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | ★ 2.15 | N/A |
| Revenue | ★ $914,857,000.00 | $1,535,000.00 |
| Revenue This Year | $17.50 | $499.13 |
| Revenue Next Year | $5.12 | $893.14 |
| P/E Ratio | $10.43 | ★ N/A |
| Revenue Growth | 3.98 | ★ 47.74 |
| 52 Week Low | $16.40 | $24.10 |
| 52 Week High | $23.43 | $57.99 |
Technical Indicators
Market Signals| Indicator | FBP | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 36.05 |
| Support Level | $22.02 | $43.94 |
| Resistance Level | $23.43 | $48.58 |
| Average True Range (ATR) | 0.66 | 2.53 |
| MACD | -0.04 | -0.77 |
| Stochastic Oscillator | 45.34 | 5.33 |
Price Performance
Historical ComparisonAbout FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.